Credit Suisse’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-124,000
| Closed | -$12.8M | – | 4042 |
|
|
2021
Q4 | $12.8M | Sell |
124,000
-294,600
| -70% | -$34.1M | 0.01% | 1321 |
|
|
2021
Q3 | $52.5M | Sell |
418,600
-78,400
| -16% | -$10.1M | 0.03% | 622 |
|
|
2021
Q2 | $61.9M | Sell |
497,000
-398,800
| -45% | -$50.1M | 0.03% | 582 |
|
|
2021
Q1 | $106M | Sell |
895,800
-64,200
| -7% | -$7.52M | 0.05% | 391 |
|
|
2020
Q4 | $112M | Sell |
960,000
-53,200
| -5% | -$5.86M | 0.06% | 374 |
|
|
2020
Q3 | $105M | Buy |
1,013,200
+544,100
| +116% | +$54.6M | 0.06% | 331 |
|
|
2020
Q2 | $43M | Buy |
469,100
+108,200
| +30% | +$10.4M | 0.03% | 595 |
|
|
2020
Q1 | $32.5M | Sell |
360,900
-327,900
| -48% | -$34.9M | 0.03% | 602 |
|
|
2019
Q4 | $78.1M | Buy |
688,800
+401,900
| +140% | +$44.1M | 0.06% | 369 |
|
|
2019
Q3 | $31.2M | Sell |
286,900
-153,500
| -35% | -$16M | 0.03% | 676 |
|
|
2019
Q2 | $42.9M | Buy |
440,400
+267,100
| +154% | +$24.4M | 0.04% | 511 |
|
|
2019
Q1 | $15.8M | Buy |
173,300
+121,200
| +233% | +$10.8M | 0.01% | 990 |
|
|
2018
Q4 | $4.74M | Buy |
52,100
+17,100
| +49% | +$1.6M | ﹤0.01% | 1618 |
|
|
2018
Q3 | $3.44M | Sell |
35,000
-100,000
| -74% | -$9.25M | ﹤0.01% | 1949 |
|
|
2018
Q2 | $11.6M | Sell |
135,000
-275,000
| -67% | -$23M | 0.01% | 1153 |
|
|
2018
Q1 | $32.9M | Buy |
410,000
+375,000
| +1,071% | +$30.9M | 0.03% | 599 |
|
|
2017
Q4 | $2.83M | Buy |
+35,000
| New | +$2.8M | ﹤0.01% | 2177 |
|
|
2017
Q2 | – | Sell |
-111,500
| Closed | -$8.98M | – | 3910 |
|
|
2017
Q1 | $8.98M | Buy |
111,500
+81,500
| +272% | +$6.37M | 0.01% | 1280 |
|
|
2016
Q4 | $2.14M | Buy |
+30,000
| New | +$2.36M | ﹤0.01% | 2388 |
|
|
2016
Q2 | – | Sell |
-100,000
| Closed | -$7.5M | – | 4290 |
|
|
2016
Q1 | $7.5M | Buy |
100,000
+20,000
| +25% | +$1.51M | 0.01% | 1276 |
|
|
2015
Q4 | $6.15M | Buy |
+80,000
| New | +$6.02M | 0.01% | 1434 |
|
|
2014
Q4 | – | Sell |
-300,000
| Closed | -$18.6M | – | 4674 |
|
|
2014
Q3 | $18.6M | Hold |
300,000
| – | – | 0.02% | 957 |
|
|
2014
Q2 | $19.1M | Buy |
+300,000
| New | +$18.2M | 0.02% | 961 |
|
|
2014
Q1 | – | Sell |
-102,500
| Closed | -$5.88M | – | 4784 |
|
|
2013
Q4 | $5.88M | Buy |
102,500
+38,800
| +61% | +$2.2M | 0.01% | 1706 |
|
|
2013
Q3 | $3.39M | Buy |
63,700
+11,500
| +22% | +$619K | ﹤0.01% | 1949 |
|
|
2013
Q2 | $2.69M | Buy |
+52,200
| New | +$2.58M | ﹤0.01% | 2044 |
|
Other funds holding MDT
Credit Suisse's MDT Position: Q1 2024 in Review
Credit Suisse reduced its Medtronic (MDT) stake by 7.9% in Q1 2024, selling an estimated $12.2M and leaving 1,664,769 shares worth $145M. The position accounts for 0.14% of the portfolio, ranked #134.
Credit Suisse first reported a position in MDT in Q2 2013 and has held it in 43 quarters since. The position peaked at $332M in Q4 2019. 2,075 funds tracked by Wall St. Rank hold MDT as of Q1 2024.
- Credit Suisse held 1,664,769 shares of Medtronic worth $145M as of Q1 2024.
- Credit Suisse sold 142,649 Medtronic shares in Q1 2024, an estimated $12.2M.
- Medtronic made up 0.14% of Credit Suisse's portfolio in Q1 2024, its #134 holding.
- Credit Suisse first reported a position in Medtronic in Q2 2013 and has held it in 43 quarters since.
- Credit Suisse's Medtronic position peaked at $332M in Q4 2019.
- 2,075 funds tracked by Wall St. Rank held Medtronic as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.